Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

AGM Presentation

November 12, 2015August 16, 2022 Alterity Therapeutics

2015_11_13 Prana AGM Presentation 2

2015

Post navigation

Prana AGM Webcast Details

Prana Maintains NASDAQ Listing

Related Posts

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson’s Disease

January 28, 2022August 16, 2022

Dr David Stamler China Investor & Partnering Symposium Webcast

March 15, 2018August 16, 2022

Alterity AGM Investor Conference Call

November 20, 2019August 16, 2022

Recent Posts

Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Chairman’s Address 2024 Annual General Meeting
AGM 2024 Presentation
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065